Literature DB >> 24995179

Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution.

Indu Biswal1, Balvinder Singh Arora2, Dimple Kasana3.   

Abstract

CONTEXT: Pseudomonas aeruginosa is an important pathogen which causes nosocomial infections in immunocompromised patients, especially in hospitalized burn patients. In recent times, it has emerged as a widespread Multi Drug Resistant (MDR) pathogen which requires antibiotic susceptibility testing on a regular as well as a periodic basis. AIM OF THE STUDY: The present study was undertaken to determine the antibiogram of P. aeruginosa which was isolated from inpatients and environmental sources, and to type the strains, based on their antibiogram patterns. SETTINGS AND
DESIGN: A prospective study was undertaken with 525 samples (blood and wound swabs) which were taken from 60 patients who were admitted to Vardhman Mahavir Medical College and Safdarjang hospital with burn injuries and with 101 samples which were obtained from environmental sources viz. surgical instruments, dressings, suction devices, sinks, antiseptic solutions, etc.
MATERIALS AND METHODS: The strains were cultured and identified by standard microbiological techniques and Kirby- Bauer disc diffusion antibiotic susceptibility testing was done for each. STATISTICAL ANALYSIS: Chi -squire tests were done and p- values of less than 0.05 were considered to be significant.
RESULTS: Fifty six strains and two strains, respectively, of P. aeruginosa were isolated from inpatients and environmental samples (one strain from sink and one strain from door wall, among the two) respectively. In total, 58 (81%) P. aeruginosa strains were found to be resistant to aminoglycosides, 41-70% were resistant to beta-lactams - piperacillin, ceftazidime, and aztreonam, 34.5% were resistant to piperacillin-tazobactam, 12.06% were resistant to ciprofloxacin and 13-19% were resistant to carbapenems. All strains were sensitive to colistin. P. aeruginosa was resistant to three of the four 'in-use' drugs i.e. piperacillin+tazobactam, imipenem, ceftazidime, and gentamicin, which was taken as MDR, which depicted MDR percentage as 36.2 (21/58).
CONCLUSION: Strategies of optimal prescribing, including control of antibiotic usage, coupled with periodic studies on MDR P. aeruginosa infections in burn patients, appear to be leading priorities which help in improving therapeutic gains in such patients.

Entities:  

Keywords:  Antibiotyping; Multidrug resistance; Pseudomonas aeruginosa

Year:  2014        PMID: 24995179      PMCID: PMC4080000          DOI: 10.7860/JCDR/2014/7483.4383

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Bacteriology of burn wounds--the first three years in a new burn unit at the Medical College Chandigarh.

Authors:  R Kaushik; S Kumar; R Sharma; P Lal
Journal:  Burns       Date:  2001-09       Impact factor: 2.744

Review 2.  A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.

Authors:  M A Pfaller; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1997-08       Impact factor: 2.803

3.  Phenotypic screening of extended-spectrum ß-lactamase and metallo-ß-lactamase in multidrug-resistant Pseudomonas aeruginosa from infected burns.

Authors:  M Vahdani; L Azimi; B Asghari; F Bazmi; A Rastegar Lari
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

4.  Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents.

Authors:  Y Carmeli; N Troillet; G M Eliopoulos; M H Samore
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA).

Authors:  M A Pfaller; R N Jones; D J Biedenbach
Journal:  Diagn Microbiol Infect Dis       Date:  2001-12       Impact factor: 2.803

6.  Aerobic bacterial isolates from burn wound infections and their antibiograms--a five-year study.

Authors:  N Agnihotri; V Gupta; R M Joshi
Journal:  Burns       Date:  2004-05       Impact factor: 2.744

7.  Epidemiology of hospitalized burn patients in a tertiary care hospital in South India.

Authors:  Sivaram Ganesamoni; Vikram Kate; Jagdish Sadasivan
Journal:  Burns       Date:  2009-09-25       Impact factor: 2.744

8.  A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North India.

Authors:  Neelam Taneja; Rekha Emmanuel; P S Chari; Meera Sharma
Journal:  Burns       Date:  2004-11       Impact factor: 2.744

9.  Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.

Authors:  Gamal F Gad; Ramadan A El-Domany; Sahar Zaki; Hossam M Ashour
Journal:  J Antimicrob Chemother       Date:  2007-09-29       Impact factor: 5.790

10.  Antimicrobial susceptibility pattern of aerobic microbial isolates in a clinical laboratory in Karachi - Pakistan.

Authors:  Rubina Sabir; S Faraz Danish Alvi; Asher Fawwad
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

View more
  11 in total

1.  Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing.

Authors:  Matthew B Lawrenz; Ashley E Biller; Daniel E Cramer; Jennifer L Kraenzle; Julie B Sotsky; Carol D Vanover; Deborah R Yoder-Himes; Angela Pollard; Jonathan M Warawa
Journal:  Pathog Dis       Date:  2015-04-09       Impact factor: 3.166

2.  Adjuvant Antibiotic Activity of Acidic Sophorolipids with Potential for Facilitating Wound Healing.

Authors:  Helen L Lydon; Niki Baccile; Breedge Callaghan; Roger Marchant; Christopher A Mitchell; Ibrahim M Banat
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Multidrug-Resistant and Extremely Drug-Resistant Pseudomonas aeruginosa in Clinical Samples From a Tertiary Healthcare Facility in Nigeria.

Authors:  Amaka Marian Awanye; Chidozie Ngozi Ibezim; Catherine Nonyelum Stanley; Hannah Onah; Iheanyi Omezurike Okonko; Nkechi Eucharia Egbe
Journal:  Turk J Pharm Sci       Date:  2022-08-31

4.  Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Pseudomonas aeruginosa Isolates from Burn Patients.

Authors:  Seyed Abolfazl Hosseininassab Nodoushan; Sima Yadegari; Sharareh Moghim; Bahram Nasr Isfahani; Hossein Fazeli; Farkhondeh Poursina; Pourya Nasirmoghadas; Hajieh Ghasemian Safaei
Journal:  Adv Biomed Res       Date:  2017-06-27

5.  The Effects of Berberine and Palmatine on Efflux Pumps Inhibition with Different Gene Patterns in Pseudomonas aeruginosa Isolated from Burn Infections.

Authors:  Seyed Sajjad Aghayan; Hamidreza Kalalian Mogadam; Mozhgan Fazli; Davood Darban-Sarokhalil; Seyed Sajjad Khoramrooz; Fereshteh Jabalameli; Somayeh Yaslianifard; Mehdi Mirzaii
Journal:  Avicenna J Med Biotechnol       Date:  2017 Jan-Mar

6.  Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran.

Authors:  Jamshid Faghri; Samereh Nouri; Saba Jalalifar; Mehrdad Zalipoor; Mehrdad Halaji
Journal:  BMC Res Notes       Date:  2018-11-12

7.  Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption.

Authors:  Ághata Cardoso da Silva Ribeiro; Márcia Terezinha Lonardoni Crozatti; Adilson Aderito da Silva; Rodrigo Spineli Macedo; Antonia Maria de Oliveira Machado; Antonio Távora de Albuquerque Silva
Journal:  Rev Soc Bras Med Trop       Date:  2019-12-20       Impact factor: 1.581

8.  Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a burn center.

Authors:  Pezhman Karami; Parviz Mohajeri; Rasool Yousefi Mashouf; Manoochehr Karami; Mojtaba Hedayat Yaghoobi; Dara Dastan; Mohammad Yousef Alikhani
Journal:  Saudi J Biol Sci       Date:  2018-07-20       Impact factor: 4.219

9.  Isolation, characterization, and effectiveness of bacteriophage Pɸ-Bw-Ab against XDR Acinetobacter baumannii isolated from nosocomial burn wound infection.

Authors:  Ladan Rahimzadeh Torabi; Monir Doudi; Nafiseh Sadat Naghavi; Ramesh Monajemi
Journal:  Iran J Basic Med Sci       Date:  2021-09       Impact factor: 2.699

10.  Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition.

Authors:  Fithamlak Bisetegen Solomon; Fiseha Wadilo; Efrata Girma Tufa; Meseret Mitiku
Journal:  Antimicrob Resist Infect Control       Date:  2017-10-23       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.